Literature DB >> 15280500

Characterization of the mouse adeno-associated virus AAVS1 ortholog.

Nathalie Dutheil1, Miran Yoon-Robarts, Peter Ward, Els Henckaerts, Lucy Skrabanek, Kenneth I Berns, Fabien Campagne, R Michael Linden.   

Abstract

The nonpathogenic human adeno-associated virus (AAV) has developed a mechanism to integrate its genome into human chromosome 19 at 19q13.4 (termed AAVS1), thereby establishing latency. Here, we provide evidence that the chromosomal signals required for site-specific integration are conserved in the mouse genome proximal to the recently identified Mbs85 gene. These sequence motifs can be specifically nicked by the viral Rep protein required for the initiation of site-specific AAV DNA integration. Furthermore, these signals can serve as a minimal origin for Rep-dependent DNA replication. In addition, we isolated the mouse Mbs85 proximal promoter and show transcriptional activity in three mouse cell lines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280500      PMCID: PMC479059          DOI: 10.1128/JVI.78.16.8917-8921.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Identification of active site residues of the adeno-associated virus type 2 Rep endonuclease.

Authors:  Miran Yoon-Robarts; R Michael Linden
Journal:  J Biol Chem       Date:  2002-12-11       Impact factor: 5.157

2.  The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity.

Authors:  D S Im; N Muzyczka
Journal:  Cell       Date:  1990-05-04       Impact factor: 41.582

3.  Site-specific integration by adeno-associated virus.

Authors:  R M Kotin; M Siniscalco; R J Samulski; X D Zhu; L Hunter; C A Laughlin; S McLaughlin; N Muzyczka; M Rocchi; K I Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter.

Authors:  R M Kotin; J C Menninger; D C Ward; K I Berns
Journal:  Genomics       Date:  1991-07       Impact factor: 5.736

5.  Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization.

Authors:  D S Im; N Muzyczka
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  Biologically active Rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli.

Authors:  J A Chiorini; M D Weitzman; R A Owens; E Urcelay; B Safer; R M Kotin
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA.

Authors:  M D Weitzman; S R Kyöstiö; R M Kotin; R A Owens
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

8.  Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.

Authors:  J C Bakowska; M V Di Maria; S M Camp; Y Wang; P D Allen; X O Breakefield
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

9.  Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination.

Authors:  R M Kotin; R M Linden; K I Berns
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  Targeted integration of adeno-associated virus (AAV) into human chromosome 19.

Authors:  R J Samulski; X Zhu; X Xiao; J D Brook; D E Housman; N Epstein; L A Hunter
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  12 in total

Review 1.  Safe harbours for the integration of new DNA in the human genome.

Authors:  Michel Sadelain; Eirini P Papapetrou; Frederic D Bushman
Journal:  Nat Rev Cancer       Date:  2011-12-01       Impact factor: 60.716

Review 2.  Targeting site-specific chromosome integration.

Authors:  Patricia Nuno-Gonzalez; Hsu Chao; Kazuhiro Oka
Journal:  Acta Biochim Pol       Date:  2005-06-03       Impact factor: 2.149

3.  Genotoxicity in Mice Following AAV Gene Delivery: A Safety Concern for Human Gene Therapy?

Authors:  Randy J Chandler; Matthew C LaFave; Gaurav K Varshney; Shawn M Burgess; Charles P Venditti
Journal:  Mol Ther       Date:  2016-02       Impact factor: 11.454

4.  Characterization of adeno-associated virus genomes isolated from human tissues.

Authors:  Bruce C Schnepp; Ryan L Jensen; Chun-Liang Chen; Philip R Johnson; K Reed Clark
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Adeno-associated virus site-specific integration is regulated by TRP-185.

Authors:  Noriaki Yamamoto; Masato Suzuki; Masa-Aki Kawano; Takamasa Inoue; Ryou-U Takahashi; Hiroko Tsukamoto; Teruya Enomoto; Yuki Yamaguchi; Tadashi Wada; Hiroshi Handa
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

6.  Herpes simplex virus type 1/adeno-associated virus hybrid vectors.

Authors:  Anna Paula de Oliveira; Cornel Fraefel
Journal:  Open Virol J       Date:  2010-06-18

7.  Transcriptional analysis of the adeno-associated virus integration site.

Authors:  Nathalie Dutheil; Els Henckaerts; Erik Kohlbrenner; R Michael Linden
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

8.  Site-specific integration of adeno-associated virus involves partial duplication of the target locus.

Authors:  Els Henckaerts; Nathalie Dutheil; Nadja Zeltner; Steven Kattman; Erik Kohlbrenner; Peter Ward; Nathalie Clément; Patricia Rebollo; Marion Kennedy; Gordon M Keller; R Michael Linden
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

9.  Adeno-associated virus: a key to the human genome?

Authors:  Els Henckaerts; R Michael Linden
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

10.  Myosin phosphatase is inactivated by caspase-3 cleavage and phosphorylation of myosin phosphatase targeting subunit 1 during apoptosis.

Authors:  Takahiro Iwasaki; Takeshi Katayama; Kazuhiro Kohama; Yaeta Endo; Tatsuya Sawasaki
Journal:  Mol Biol Cell       Date:  2013-01-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.